• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Study links coffee, genetics and Parkinson's disease prevention

Study links coffee, genetics and Parkinson's disease prevention

February 6, 2012
CenterWatch Staff

A recent study co-authored by Evergreen Healthcare neurologist Dr. Pinky Agarwal finds good news for coffee drinkers: consuming caffeinated coffee may significantly reduce the risk of Parkinson's disease in some individuals depending on their genetics, according to research recently published by the Public Library of Science.

Parkinson's disease, which affects more than 50,000 Americans each year, is a progressive disorder of the central nervous system that affects movement. According to the study, researchers identified a connection between coffee's protective qualities and a gene known as GRIN2A, which regulates brain signals that control movement and behavior.

On average, heavy coffee drinkers were found to have a 27% lower risk of developing Parkinson's disease, regardless of the genes they carry. The risk was even less for heavy coffee drinkers who carry a specific variation of GRIN2A, with a 59% lower chance.

"Researchers have long studied the relationship between coffee and Parkinson's disease with results often showing that all people do not benefit equally from consuming varying amounts of caffeinated coffee,” said Agarwal. “Through this study, we have proven the benefits of using genetic evidence to determine new risk factors for Parkinson's. We think the results will contribute to more personalized treatment for and prevention of this disease."

Agarwal co-authored the study alongside a team of nationally recognized specialists within a range of fields including oncology, epidemiology, neurology, genetics and environmental health studies.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing